The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Illegal immigrant accused of assaulting NJ teen could be released under sanctuary policies, ICE warns
Long Island teen who vanished after trip to NYC found dead in Brooklyn waters
Who is Ayman Mohamad Ghazali? Lebanese-born American accused in Jewish synagogue attack
BREAKING: Trump Says New Ayatollah Still Alive ‘In Some Form’
Sen Schmitt reups push for expanding denaturalization after recent acts of violence by naturalized citizens
Doctor denies knowing about rampant LA-area Medicare fraud using his provider number
Mamdani touts landmark court victory against repeat offender landlord in housing enforcement push
California mountain biker dies after month-long hospital stay following rattlesnake bite
Soros-backed DA sparks backlash after blaming Old Dominion shooting on pro-gun lawmakers: ‘F— right off’
Illegal alien’s violent tussle with federal officer leads to multiple charges after suspected Biden-era entry
Trump admin’s push to end controversial policy extended by Biden sparks backlash ahead of crucial deadline
US Military Plane Lost Amid ‘Operation Epic Fury’: US Central Command
Report: Veteran CBS Reporter Quit After Network Refused to Obsess Over Jan. 6 Anniversary
Thune Announces He’s Bringing SAVE America Act to Senate Floor, Forcing Dems to Go on Record Opposing 83 Percent of Americans
Actress Katherine Heigl Fires Back After She’s Criticized for Attending Mar-a-Lago Event
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Illegal immigrant accused of assaulting NJ teen could be released under sanctuary policies, ICE warns
Long Island teen who vanished after trip to NYC found dead in Brooklyn waters
Who is Ayman Mohamad Ghazali? Lebanese-born American accused in Jewish synagogue attack
BREAKING: Trump Says New Ayatollah Still Alive ‘In Some Form’
Sen Schmitt reups push for expanding denaturalization after recent acts of violence by naturalized citizens
Doctor denies knowing about rampant LA-area Medicare fraud using his provider number
Mamdani touts landmark court victory against repeat offender landlord in housing enforcement push
California mountain biker dies after month-long hospital stay following rattlesnake bite
Soros-backed DA sparks backlash after blaming Old Dominion shooting on pro-gun lawmakers: ‘F— right off’
Illegal alien’s violent tussle with federal officer leads to multiple charges after suspected Biden-era entry
Trump admin’s push to end controversial policy extended by Biden sparks backlash ahead of crucial deadline
US Military Plane Lost Amid ‘Operation Epic Fury’: US Central Command
Report: Veteran CBS Reporter Quit After Network Refused to Obsess Over Jan. 6 Anniversary
Thune Announces He’s Bringing SAVE America Act to Senate Floor, Forcing Dems to Go on Record Opposing 83 Percent of Americans
Actress Katherine Heigl Fires Back After She’s Criticized for Attending Mar-a-Lago Event
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
